[1] LV W, YU M, YANG Q, et al.Total flavonoids of Rhizoma drynariae ameliorate steroid‑induced avascular necrosis of the femoral head via the PI3K/AKT pathway. Mol Med Rep. 2021;23(5):345.
[2] CHANG C, GREENSPAN A, GERSHWIN ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020;110:102460.
[3] SUN F, ZHOU JL, WEI SX, et al. Glucocorticoids induce osteonecrosis of the femoral head in rats via PI3K/AKT/FOXO1 signaling pathway. PeerJ. 2022;10: e13319.
[4] LIN T, CHEN W, YANG P, et al. Bioinformatics analysis and identification of genes and molecular pathways in steroid-induced osteonecrosis of the femoral head. J Orthop Surg Res. 2021;16(1):327.
[5] HAN N, QIAN F, NIU X, et al. Circ_0058792 regulates osteogenic differentiation through miR-181a-5p/Smad7 axis in steroid-induced osteonecrosis of the femoral head. Bioengineered. 2022;13(5):12807-12822.
[6] ZHANG X, YOU JM, DONG XJ, et al.Administration of mircoRNA-135b-reinforced exosomes derived from MSCs ameliorates glucocorticoid-induced osteonecrosis of femoral head (ONFH) in rats. J Cell Mol Med. 2020;24(23): 13973-13983.
[7] LIANG JQ, ZHOU Z AO, BO L, et al. Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone through activation of Nrf2 signaling cascade. Cell Death Dis. 2021;12(11):964.
[8] WANG Q, YANG Q, CHEN G, et al. LncRNA expression profiling of BMSCs in osteonecrosis of the femoral head associated with increased adipogenic and decreased osteogenic differentiation. Sci Rep. 2018;8(1):9127.
[9] XU Z, LV B, QIN Y, et al. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases. Cells. 2022;11(7):1101.
[10] HE PC, HE C. m6 A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40(3):e105977.
[11] MURAKAMI S, JAFFREY SR. Hidden codes in mRNA: Control of gene expression by m(6)A. Mol Cell. 2022;82(12):2236-2251.
[12] Ye L, Fan Z, Yu B, et al. Histone Demethylases KDM4B and KDM6B Promote Osteogenic Differentiation of Human MSCs. Cell Stem Cell. 2018;23(6):898-899.
[13] CHENG C, ZHANG H, ZHENG J, et al. METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6. Aging (Albany NY). 2021;13(24): 25903-25919.
[14] PAROLA C, NEUMEIER D, REDDY ST. Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering.Immunology. 2018;153(1):31-41.
[15] RITCHIE M E, PHIPSON B, WU D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
[16] ZHOU L Q, SHEN J X, ZHOU J Y, et al. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database.Sci Rep. 2022;12(1):579.
[17] TANG C, KLUKOVICH R, PENG H, et al. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3’-UTR mRNAs in male germ cells. Proc Natl Acad Sci U S A. 2018;115(2):E325-E333.
[18] KULESHOV MV, JONES MR, ROUILLARD AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90-W97.
[19] WANG S, MATSUMOTO K, LISH SR, et al. Budding epithelial morphogenesis driven by cell-matrix versus cell-cell adhesion. Cell. 2021;184(14):3702-3716.
[20] CHAI Q, YU S, ZHONG Y, et al. A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin. Science. 2022;378(6616):eabq0132.
[21] TAKEDA K, AKIRA S. TLR signaling pathways. Semin Immunol. 2004;16(1):3-9.
[22] ZHANG S, WANG C, SHI L, et al. Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic. Drug Des Devel Ther. 2021;15:983-995.
[23] NAN K, ZHANG Y, ZHANG X, et al. Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu). Stem Cell Res Ther. 2021;12(1):331.
[24] 王毅.成人股骨头缺血性坏死患者临床症状、CT与MRI影像学表现特点分析[J].中国CT和MRI杂志,2021,19(9):176-179.
[25] WANG B, GONG S, SHAO W, et al. Comprehensive analysis of pivotal biomarkers, immune cell infiltration and therapeutic drugs for steroid-induced osteonecrosis of the femoral head. Bioengineered. 2021;12(1):5971-5984.
[26] SALIMINEJAD K, KHORRAM KHORSHID HR, SOLEYMANI FARD S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451-5465.
[27] Liu GZ, Chen C, Kong N, et al. Identification of potential miRNA biomarkers for traumatic osteonecrosis of femoral head. J Cell Physiol. 2020; 235(11):8129-8140.
[28] XU P, CHANG J, MA G, et al. MiR-145 inhibits the differentiation and proliferation of bone marrow stromal mesenchymal stem cells by GABARAPL1 in steroid-induced femoral head necrosis. BMC Musculoskelet Disord. 2022;23(1):1020.
[29] LIN L, YU Y, LIU K, et al. Downregulation of miR-30b-5p Facilitates Chondrocyte Hypertrophy and Apoptosis via Targeting Runx2 in Steroid-Induced Osteonecrosis of the Femoral Head. Int J Mol Sci. 2022;23(19):11275.
[30] ZHANG L, HOU C, CHEN C, et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):105.
[31] DAS MANDAL S, RAY PS. Transcriptome-wide analysis reveals spatial correlation between N6-methyladenosine and binding sites of microRNAs and RNA-binding proteins. Genomics. 2021;113(1 Pt 1):205-216.
[32] LI L, XU N, LIU J, et al. m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential. Front Genet. 2022;13:908976.
[33] BAI Q, SHI M, SUN X, et al. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis. Front Endocrinol (Lausanne). 2022;13:957742.
[34] FANG R, CHEN X, ZHANG S, et al. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat Commun. 2021;12(1):177.
[35] 黄涛, 崔泳. miRNA-27α调控PPARγ/ApoA5通路对大鼠激素性股骨坏死的影响研究[J].实用骨科杂志,2021,27(4):330-334.
[36] Park-Min KH. Metabolic reprogramming in osteoclasts. Semin Immunopathol. 2019;41(5):565-572.
[37] TAUBMANN J, KRISHNACOUMAR B, BÖHM C, et al.Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis. Sci Rep. 2020;10(1):21020.
[38] CHEN K, LIU Y, HE J, et al. Steroid-induced osteonecrosis of the femoral head reveals enhanced reactive oxygen species and hyperactive osteoclasts.Int J Biol Sci. 2020;16(11):1888-1900.
[39] 梁学振,骆帝,李嘉程,等.激素性股骨头坏死中的PTGS2和STAT3:潜在铁死亡相关诊断生物标志物[J].中国组织工程研究,2023,27(36): 5898-5904. |